Industry Developments
Ethiopia
The potential for returns on pharmaceutical investment in Ethiopia are great given the large population, favourable demographic and epidemiological trends, as well as its position as...
2013-05-17Algeria
Although PhRMA is encouraged by the Algerian government's intention to improve its pharmaceutical policies, it is evident that the Ministry of Health continues to make the entire process...
2013-05-16Lebanon
BMI View: In Lebanon, poor intellectual property protection of innovative medicines is based on the ease with which the Ministry of Health allows generic equivalents to enter the market....
2013-05-15South Africa
BMI View: Increasing competition in the bid to partially or completely buy out South African drugmaker Adcock Ingram, as well as strong revenue growth outlooks for the company in 2013...
2013-05-14Egypt
BMI View: A minor downgrade of Egypt's credit rating will not have a significant impact on the cost of borrowing for local drugmakers and subsequent overall cost of pharmaceutical...
2013-05-13One of the strategies adopted by multinational pharmaceutical companies in developing African markets is to improve market access by adopting a low-price, high-volume business model...
2013-05-10Ghana
Reliance on finished pharmaceutical imports is necessary in emerging African economies, to ensure a constant medicines supply while local production capabilities remain largely erratic....
2013-05-07BMI View: Egypt will remain the largest healthcare market in the North African region in the medium term. This is despite the country's increasing political risk profile and further...
2013-05-03
